Global Pipeline of Innovative Medicinal Products: A Narrative Review

QR Code

Global Pipeline of Innovative Medicinal Products: A Narrative Review

SCIENTIFIC RELEVANCE. The rapid expansion of the range of medicines in the global pharmaceutical market determines the importance of periodically reviewing the range of innovative medicines and products at various stages of development.AIM. This study aimed to determine the main trends in the develo...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. A. Merkulov, R. I. Yagudina, V. G. Serpik
Format:	Article
Language:	Russian
Published:	Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2024-02-01
Series:	Регуляторные исследования и экспертиза лекарственных средств
Subjects:	innovative medicinal products cost of medicinal products value of medicinal products pipeline alzheimer’s disease gene therapy cell therapy rna therapy
Online Access:	https://www.vedomostincesmp.ru/jour/article/view/579
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Current challenges and future directions of ATMPs in regenerative medicine
by: Fatemeh Abbasi Kakroodi, et al.
Published: (2025-12-01)

Cell-based medicinal products: a review of current research
by: E. V. Galitsyna, et al.
Published: (2024-12-01)

Current Trends in the Use of Cell Therapy in Regenerative Medicine
by: A. A. Chaplenko, et al.
Published: (2020-06-01)

Applied Research Conference “Current Approaches to Evaluation of Medicinal Products” (RegLek 2020)
by: article Editorial
Published: (2020-12-01)

Quality control programmes for induced pluripotent stem cell-derived medicinal products
by: E. V. Melnikova, et al.
Published: (2025-06-01)

Special Provisions for the Medicines Registration Procedure in Response to Economic Restrictions Imposed on the Russian Federation
by: E. M. Rychikhina
Published: (2022-07-01)

Gene Therapy Medicinal Products: Non-clinical Safety Studies
by: O. V. Astapova, et al.
Published: (2023-03-01)

Possibilities of using one-component and multicomponent phyto- and bioregulatory preparations in children
by: E. V. Konopleva
Published: (2021-06-01)

Actions of the Manufacturers of Herbal and Other High-Demand Medicinal Products According to the EAEU Authorisation Procedures: Practical Recommendations
by: E. M. Rychikhina
Published: (2024-04-01)

World practice of providing scientific advice on the development and authorisation of innovative medicines
by: E. V. Melnikova, et al.
Published: (2021-10-01)

Methodological Approaches to Risk Management of Advanced Therapy Medicinal Products
by: A. A. Taube, et al.
Published: (2023-09-01)

The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies
by: A. S. Kolbin, et al.
Published: (2022-04-01)

Integrative approaches in Alzheimer’s disease: evaluating the potential of traditional, complementary, and integrative medicine (TCIM)
by: R. Sneha Sri, et al.
Published: (2025-06-01)

Current Trends in the Study of Promising Medicinal Plant Species
by: N. I. Sidelnikov
Published: (2024-04-01)

Application of therapeutic nucleic acids and RNA interference to create products for personalised medicine
by: I. P. Shilovskiy, et al.
Published: (2024-07-01)

Centralized procedure for authorization of veterinary medicinal products
by: Simona Sturzu
Published: (2010-06-01)

Strategic Indicators in the Development of Original Medicinal Products in 2024: Analysis of Pipelines of International Pharmaceutical Leaders
by: L. S. Litvin, et al.
Published: (2023-08-01)

THE EFFICACY AND SAFETY PROFILE OF ADVANCED THERAPY MEDICINAL PRODUCTS IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
by: R. N. Alyautdin, et al.
Published: (2022-05-01)

Challenges in development and authorisation of gene therapy products
by: A. A. Soldatov, et al.
Published: (2022-04-01)

Multistakeholder scientific advice for medicinal products used in combination with a medical device or a companion diagnostic in the EU—summary of a Focus group discussion
by: Stiina Aarum, et al.
Published: (2025-07-01)

The revision of the restrictive lists of medicinal products
by: B. K. Romanov, et al.
Published: (2018-02-01)

Foreign Experience of Applying the Principle of "Pump or Pay" in the Field of Pipeline Transportation
by: V. I. Salygin, et al.
Published: (2015-08-01)

The PROMISE of Precision Medicine in Myocardial Infarction with Non-Obstructive Coronary Arteries
by: Giulia La Vecchia, et al.
Published: (2025-04-01)

RISK ASSESSMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS
by: R. N. Alyautdin, et al.
Published: (2018-02-01)

Regulation for the Translation of Gene and Cell Therapy into Medical Practice in East Asian Countries
by: E. V. Melnikova, et al.
Published: (2024-02-01)

Learning Needs as a Reflection of Professional Interests among Health Experts
by: N. G. Goloenko, et al.
Published: (2019-03-01)

Diego Armus & Pablo F. Gómez (coord.), The Gray Zones of Medicine. Healers & History in Latin América
by: María José Correa Gómez
Published: (2022-06-01)

Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality?
by: V. I. Podzolkov, et al.
Published: (2019-03-01)

INFORMATION SYSTEM FOR EXPERT EVALUATION OF MEDICINES INTERCHANGEABILITY
by: D. P. Andreev, et al.
Published: (2018-06-01)

Current Requirements for the Degree of Fineness of Herbal Substances and Herbal Medicinal Products
by: E. L. Kovaleva, et al.
Published: (2020-12-01)

Medicines from forest products /
by: Soepardi, R.
Published: (1967)

Recommendations on Describing the Requirements for Microbiological Quality and Sterility of Medicinal Products
by: O. V. Gunar
Published: (2022-07-01)

Plant Extracts in Development of Medicinal Products of Various Therapeutic Value
by: I. P. Smirnova, et al.
Published: (2020-05-01)

Application of the <i>AlphaScreen</i> and <i>AlphaLisa</i> method in drug development and pharmacokinetic studies
by: R. T. Mukhametshina, et al.
Published: (2022-05-01)

Dynamics of the electrospondilography indices of the individuals with back pain under the influencing of the physical rehabilitation program. Physical rehabilitation of the individuals with back pain
by: O. K. Nikanorov, et al.
Published: (2019-12-01)

The Cardiovascular Therapy and Prevention journal’s top contributing institutions: Department of Therapy and Preventive Medicine of the A. I. Evdokimov Moscow State Medical University of the Ministry of Health of Russia (Moscow, Russia)
by: O. N. Dzhioeva, et al.
Published: (2023-11-01)

Specific aspects of bacteriophage regulation: international practices and future developments
by: D. S. Davydov, et al.
Published: (2024-10-01)

AYURVEDIC MEDICINAL PLANTS AND THEIR NEUROPROTECTIVE POTENTIAL IN ALZHEIMER'S DISEASE
by: Bargale Sushant Sukumar, et al.
Published: (2025-06-01)

Pharmaceutical Innovations: Artificial Intelligence and Scientific Cooperation as the Certain Future for the Pharmaceutical Industry
by: L. I. Shcherbakova, et al.
Published: (2025-05-01)

Medicinal products as a causative agent of occupational diseases in pharmaceutical workers (literature review)
by: B.P. Kuzminov, et al.
Published: (2022-12-01)